RAR-related orphan receptor alpha
RAR-related orphan receptor alpha (RORα), also known as NR1F1 (nuclear receptor subfamily 1, group F, member 1), is a nuclear receptor that plays a critical role in the regulation of several physiological processes, including circadian rhythm, immune function, and metabolic regulation. RORα is a member of the nuclear receptor family of intracellular transcription factors and is classified as an orphan receptor because its endogenous ligand was initially unknown.
Function[edit | edit source]
RORα is involved in a wide range of biological functions. It is a key regulator of the circadian clock, influencing the expression of genes involved in the maintenance of the circadian rhythm. In the immune system, RORα plays a role in the development and differentiation of various immune cells, including Th17 cells, which are important for the body's defense against pathogens and are implicated in autoimmune diseases. Additionally, RORα is involved in lipid metabolism, influencing the expression of genes involved in lipid synthesis and metabolism, and has been linked to the regulation of cholesterol levels and obesity.
Gene and Expression[edit | edit source]
The RORα gene is located on chromosome 15q22.2 in humans. It is expressed in various tissues, including the brain, liver, muscle, and immune cells, reflecting its diverse roles in the body. The expression of RORα is subject to circadian variation, particularly in the suprachiasmatic nucleus of the brain, which is the central clock of the mammalian circadian system.
Clinical Significance[edit | edit source]
Mutations in the RORα gene have been associated with several human diseases. Notably, a loss of function mutation in RORα is linked to Stargardt disease, a form of autosomal recessive juvenile macular degeneration. Additionally, variations in the RORα gene have been implicated in the development of autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis, due to its role in immune cell differentiation and function.
RORα is also being studied for its potential therapeutic implications. Given its role in lipid metabolism and obesity, RORα is a potential target for the treatment of metabolic disorders. Furthermore, modulating RORα activity has therapeutic potential in autoimmune diseases and cancer, where RORα's role in immune cell function and proliferation is relevant.
Research Directions[edit | edit source]
Research on RORα continues to uncover its complex roles in physiology and disease. Efforts are underway to identify natural and synthetic ligands for RORα that could be used to modulate its activity for therapeutic purposes. Understanding the precise mechanisms by which RORα influences gene expression and cellular function is crucial for developing targeted therapies for diseases associated with RORα dysfunction.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD